These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1926527)

  • 1. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes.
    Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of HLA matching, donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporin A and azathioprine.
    Khaghani A; Yacoub M; McCloskey D; Awad J; Burden M; Fitzgerald M; Hawes R; Holmes J; Smith J; Banner N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):799-800. PubMed ID: 2650273
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysis of endothelial cells by graft-infiltrating lymphocytes after clinical heart transplantation.
    Jutte N; Heyse P; van Batenburg M; Vaessen L; Mochtar B; Balk A; Claas F; Weimar W
    Transplant Proc; 1993 Feb; 25(1 Pt 1):100-1. PubMed ID: 8438239
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
    Kaczmarek I; Deutsch MA; Rohrer ME; Beiras-Fernandez A; Groetzner J; Daebritz S; Schmoeckel M; Spannagl M; Meiser B; Reichart B
    J Heart Lung Transplant; 2006 Sep; 25(9):1057-62. PubMed ID: 16962466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantation.
    van Emmerik NE; Loonen EH; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
    J Heart Lung Transplant; 1997 Feb; 16(2):240-9. PubMed ID: 9059936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation.
    Suberbielle C; Dorent R; Vaissier E; Nataf P; Busson M; Cabrol A; Cabrol C; Charron D; Raffoux C; Gandjbakhch I
    Transplant Proc; 1994 Feb; 26(1):245-6. PubMed ID: 8108959
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of HLA matching in heart transplantation. Collaborative Heart Transplant Study.
    Opelz G
    Transplant Proc; 1989 Feb; 21(1 Pt 1):794-6. PubMed ID: 2650297
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival.
    Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551
    [No Abstract]   [Full Text] [Related]  

  • 13. The feasibility of HLA matching for lung transplantation.
    McGee C; Fox MD; Loyd JE
    Clin Transplant; 1996 Dec; 10(6 Pt 1):564-7. PubMed ID: 8996780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
    Reinsmoen NL; Nelson K; Zeevi A
    Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA antibodies in heart transplantation.
    Vasilescu ER; Ho EK; de la Torre L; Itescu S; Marboe C; Cortesini R; Suciu-Foca N; Mancini D
    Transpl Immunol; 2004 Jan; 12(2):177-83. PubMed ID: 14967316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic mechanisms of cardiac transplant rejection.
    Duquesnoy RJ; Cramer DV
    Cardiovasc Clin; 1990; 20(2):87-103. PubMed ID: 2404607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR matching and graft survival in heart transplant.
    Valeri M; Adorno D; Piazza A; Torlone N; Provenzani L; Monaco PI; Casciani CU
    Transplant Proc; 1990 Aug; 22(4):1906-7. PubMed ID: 2389481
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation.
    Loh E; Bergin JD; Couper GS; Mudge GH
    J Heart Lung Transplant; 1994; 13(2):194-201. PubMed ID: 8031799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
    Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
    [No Abstract]   [Full Text] [Related]  

  • 20. 14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.
    Ozawa M; Terasaki PI; Castro R; Alberu J; Morales-Buenrostro L; Alvarez I; Toledo R; Alvez H; Monteiro M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Langan L; Conca R; Grosse-Wilde H; Heinemann F; Kamoun M; Kobayashi T; Kupatawintu P; LeFor W; Mehra N; Panigrahi A; Norman D; Piazza A; Poli F; Roy R; Schonemann C; Lachmann N; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
    Clin Transpl; 2007; ():255-60. PubMed ID: 18642456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.